Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1988-2-17
|
pubmed:abstractText |
Fluoxetine, a selective inhibitor of serotonin uptake, is clinically useful in treating depression and may be useful for management of a variety of other psychiatric and metabolic derangements. Using X-ray crystallography, we have determined the three-dimensional structure of fluoxetine hydrochloride. A total of 2394 unique reflections were measured, and full-matrix least-squares refinement of all non-hydrogen coordinates and thermal parameters gave a final discrepancy index of 0.074 for 1759 observed reflections. In the solid state, the planes defined by the two aromatic rings are skewed, precluding the possibility of intramolecular ring-ring interactions. The methylene units of the methylpropanamine moiety adopt the anticipated conformational relationships to minimize torsional strain. An exact antiperiplanar relationship exists between N11 and C3; the N11-C1-C2-C3 dihedral angle is -180 degrees. The C1-C2-C3-O4 dihedral angle is 60.6 degrees, indicating that the propanamine side-chain folds toward the phenoxy moiety rather than adopting a fully extended conformation. This folded three-dimensional relationship may be necessary for high-affinity interaction with the serotonin-uptake carrier and confers considerable structural homology between this portion of fluoxetine and the phenylcyclohexylamine substructure of sertraline and EXP-561. However, the nature of substituents on the phenoxy portion of fluoxetine is also critical in determining potency and selectivity in this series of compounds.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Fluoxetine,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Propylamines,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Antagonists
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
185-9
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3257267-Animals,
pubmed-meshheading:3257267-Brain,
pubmed-meshheading:3257267-Fluoxetine,
pubmed-meshheading:3257267-Kinetics,
pubmed-meshheading:3257267-Models, Molecular,
pubmed-meshheading:3257267-Molecular Conformation,
pubmed-meshheading:3257267-Norepinephrine,
pubmed-meshheading:3257267-Propylamines,
pubmed-meshheading:3257267-Rats,
pubmed-meshheading:3257267-Serotonin,
pubmed-meshheading:3257267-Serotonin Antagonists,
pubmed-meshheading:3257267-Synaptosomes,
pubmed-meshheading:3257267-X-Ray Diffraction
|
pubmed:year |
1988
|
pubmed:articleTitle |
Molecular structure of fluoxetine hydrochloride, a highly selective serotonin-uptake inhibitor.
|
pubmed:affiliation |
Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285.
|
pubmed:publicationType |
Journal Article
|